Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Randomized clinical trial of adjuvant gemcitabine chemotherapy versus
observation in resected bile duct cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF SURGERY
Volume 105, Issue 3, Pages 192-202
Publisher
Wiley
Online
2018-02-05
DOI
10.1002/bjs.10776
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial.
- (2017) Julien Edeline et al. JOURNAL OF CLINICAL ONCOLOGY
- BILCAP: A randomized clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following curative surgery for biliary tract cancer.
- (2017) J. A. Bridgewater et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma
- (2016) Young Saing Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas
- (2016) Young Saing Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
- (2016) Katsuhiko Uesaka et al. LANCET
- Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis
- (2016) Takashi Mizuno et al. SURGERY TODAY
- Is There a Role for Adjuvant Therapy in R0 Resected Gallbladder Cancer?: A Propensity Score-Matched Analysis
- (2016) Se-Il Go et al. Cancer Research and Treatment
- Hilar Cholangiocarcinoma: expert consensus statement
- (2015) John C. Mansour et al. HPB
- Pharmacokinetic Study of Adjuvant Gemcitabine Therapy for Biliary Tract Cancer following Major Hepatectomy (KHBO1101)
- (2015) Yutaka Fujiwara et al. PLoS One
- Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study
- (2014) Shogo Kobayashi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas
- (2013) T. Ebata et al. BRITISH JOURNAL OF SURGERY
- Adjuvant chemotherapy in resectable cholangiocarcinoma patients
- (2013) Kosin Wirasorn et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Hepatopancreatoduodenectomy for Cholangiocarcinoma
- (2012) Tomoki Ebata et al. ANNALS OF SURGERY
- Evolution of Surgical Treatment for Perihilar Cholangiocarcinoma
- (2012) Masato Nagino et al. ANNALS OF SURGERY
- Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
- (2012) Shahid A Khan et al. GUT
- Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
- (2012) Anne M. Horgan et al. JOURNAL OF CLINICAL ONCOLOGY
- Neither Neoadjuvant nor Adjuvant Therapy Increases Survival After Biliary Tract Cancer Resection with Wide Negative Margins
- (2012) Evan S. Glazer et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors
- (2012) Yoshiaki Murakami et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Hepatectomy With Simultaneous Resection of the Portal Vein and Hepatic Artery for Advanced Perihilar Cholangiocarcinoma
- (2010) Masato Nagino et al. ANNALS OF SURGERY
- A Step Forward in the Treatment of Advanced Biliary Tract Cancer
- (2010) Brian M. Wolpin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 Cases
- (2010) Eiichiro Suzuki et al. ONCOLOGY
- A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
- (2009) H Ueno et al. BRITISH JOURNAL OF CANCER
- Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma
- (2009) A. Kobayashi et al. BRITISH JOURNAL OF SURGERY
- Gemcitabine-Based Adjuvant Chemotherapy Improves Survival After Aggressive Surgery for Hilar Cholangiocarcinoma
- (2009) Yoshiaki Murakami et al. JOURNAL OF GASTROINTESTINAL SURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation